Abatacept in Steroid-Dependent Minimal Change Disease and CD80-uria

被引：11
|
作者：
Isom, Robert [1 ]
Shoor, Stanford [2 ]
Higgins, John [3 ]
Cara-Fuentes, Gabriel [4 ]
Johnson, Richard J. [5 ]
机构：
[1] Stanford Univ, Div Nephrol, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA
[2] Stanford Univ, Div Immunol & Rheumatol, Sch Med, Stanford, CA 94305 USA
[3] Stanford Univ, Pathol, Med Ctr, Stanford, CA 94305 USA
[4] Univ Michigan, Div Pediat Nephrol, Ann Arbor, MI 48109 USA
[5] Univ Colorado, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO USA
来源：
KIDNEY INTERNATIONAL REPORTS | 2019年 / 4卷 / 09期
关键词：
B7-1;
D O I：
10.1016/j.ekir.2019.05.1155
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1349 / 1353
页数：5
相关论文
共 50 条
  • [21] Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome
    Li, Xiayu
    Li, Heng
    Chen, Jianghua
    He, Qiang
    Lv, Rong
    Lin, Weiqin
    Li, Qun
    He, Xuelin
    Qu, Lihui
    Suya, Wang
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (06) : 1919 - 1925
  • [22] Successful treatment of steroid-dependent minimal change disease by mycophenolate mofetil in a patient with HIV-infection
    Kim, M. J.
    Hopfer, H.
    Stoeckle, M.
    Mayr, M.
    SWISS MEDICAL WEEKLY, 2010, 140 : 15S - 15S
  • [23] Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis
    Zhao, Chenyang
    Cui, Zhao
    Zhang, Yimiao
    Wang, Fang
    Wang, Xin
    Cheng, Xuyang
    Meng, Liqiang
    Liu, Gang
    Zhao, Minghui
    CHINESE MEDICAL JOURNAL, 2022, 135 (07) : 866 - 868
  • [24] Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis
    Zhao Chenyang
    Cui Zhao
    Zhang Yimiao
    Wang Fang
    Wang Xin
    Cheng Xuyang
    Meng Liqiang
    Liu Gang
    Zhao Minghui
    中华医学杂志英文版, 2022, 135 (07) : 866 - 868
  • [25] The use of enteric-coated mycophenolate sodium in the treatment of relapsing and steroid-dependent minimal change disease
    Siu, Yui-Pong
    Tong, Matthew Ka-Hang
    Leung, Kay-Tai
    Kwan, Tze-Hoi
    Au, Tak-Cheung
    JOURNAL OF NEPHROLOGY, 2008, 21 (01) : 127 - 131
  • [26] Treatment of steroid-dependent minimal change-nephrotic syndrome with mycophenolate mofetil
    Noroña, B
    Valentín, M
    Gutiérrez, E
    Praga, M
    NEFROLOGIA, 2004, 24 (01): : 79 - 82
  • [27] Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome
    Niu, Xiao-Ling
    Hao, Sheng
    Wang, Ping
    Zhang, Wei
    Guo, Gui-Mei
    Wu, Ying
    Kuang, Xin-Yu
    Zhu, Guang-Hua
    Huang, Wen-Yan
    BIOMEDICAL REPORTS, 2016, 5 (02) : 237 - 242
  • [28] Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?
    Hofstra, Julia M.
    Deegens, Jeroen K. J.
    Wetzels, Jack F. M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (07) : 2100 - 2102
  • [29] Minimal Change Disease: A CD80 podocytopathy?
    Ishimoto, Takuji
    Shimada, Michiko
    Araya, Carlos E.
    Huskey, Janna
    Garin, Eduardo H.
    Johnson, Richard J.
    SEMINARS IN NEPHROLOGY, 2011, 31 (04) : 320 - 325
  • [30] EXTENDED LOW DOSE RITUXIMAB REGIMEN FOR THE TREATMENT OF ADULT PATIENTSWITH STEROID-DEPENDENT AND FREQUENTLY RELAPSING MINIMAL CHANGE DISEASE
    Minguez Toral, Irene
    Villacorta Perez, Javier
    Garcia Vallejo, Maria
    Sanchez Iglesias, Jorge
    Fernandez, Guillermo
    Piris, Marcos
    Caballero Cebrian, Fernando
    Casillas, Esther
    Lopes, Vanessa
    Fernandez Lucas, Milagros
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I403 - I404
12345